drugset / Trial / NCT02214927
Pharmacokinetics and Relative Bioavailability of 11634 Immediate Release Tablet in Healthy Male Volunteers
Non-randomizedParallel-groupOpen-labelTreatment
Summary
* Characterisation of the relative bioavailability of the IR-tablet vs. oral drinking solution (no primary endpoint in a statistical sense) * Safety and tolerability of the IR-tablet formulation and solution * PK profile of the single ascending doses of the IR-tablet formulation (including analysis of dose proportionality)
Timeline
- Start
- 2007-05
- Primary completion
- 2007-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 11634 | Unknown | 5 mg | Oral |
| Subject | BI 11634 | Unknown | 10 mg | Oral |
| Subject | BI 11634 | Unknown | 25 mg | Oral |
Indications
No indication recorded.